Influence of adjunctive classical homeopathy on global health status and subjective wellbeing in cancer patients - A pragmatic randomized controlled trial

Complementary Therapies in Medicine

Volumn 23, Issue 3, 2015, Pages 309-317

  Frass, Michael ^a,b   Friehs, Helmut ^b   Thallinger, Christiane ^a   Sohal, Narinderjit Kaur ^a   Marosi, Christine ^a   Muchitsch, Ilse ^c   Gaertner, Katharina ^a   Gleiss, Andreas ^a   Schuster, Ernst ^a   Oberbaum, Menachem ^d  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b WissHom (Scientific Society for Homeopathy)   (Germany)

^c Interdisciplinary Homeopathic Research Group   (Austria)

^d SHAARE ZEDEK MEDICAL CENTER   (Israel)

Author keywords

Additive homeopathy; Cancer; Global health status; Homeopathy; Subjective well being

Indexed keywords

ANTINEOPLASTIC AGENT; ARSENIC TRIOXIDE; CALCIUM CARBONATE; MERCURY SULFIDE; NUX VOMICA; PHOSPHORUS; POTASSIUM; SILICON DIOXIDE; SODIUM; SULFUR;

ADULT; ALTERNATIVE MEDICINE; ARTICLE; BREAST CANCER; CANCER GRADING; CANCER PATIENT; CLINICAL PROTOCOL; CONIUM; CONSTIPATION; CONTROLLED STUDY; CUTTLEFISH; DIARRHEA; DIGESTIVE SYSTEM CANCER; DYSPNEA; EMOTIONALITY; FATIGUE; FEMALE; FEMALE GENITAL TRACT CANCER; FUNCTIONAL ASSESSMENT; HEALTH STATUS; HEMATOLOGIC MALIGNANCY; HOMEOPATHY; HUMAN; INSOMNIA; KIDNEY CANCER; LACHESIS; LOSS OF APPETITE; LUNG CANCER; LYCOPODIUM; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; NAUSEA; NAUSEA AND VOMITING; PAIN; PROSPECTIVE STUDY; PULSATILLA; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SARCOMA; SOCIAL STATUS; THUJA; VISUAL ANALOG SCALE; VOMITING; WELLBEING; AGED; AUSTRIA; MIDDLE AGED; NEOPLASMS; PATHOPHYSIOLOGY; PSYCHOLOGY; UTILIZATION;

ADULT; AGED; AUSTRIA; COMPLEMENTARY THERAPIES; FEMALE; HEALTH STATUS; HOMEOPATHY; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PAIN; QUALITY OF LIFE;

EID: 84937632415     PISSN: 09652299     EISSN: 18736963     Source Type: Journal    
DOI: 10.1016/j.ctim.2015.03.004     Document Type: Article

References (34)

1. Navo M.A., Phan J., Vaughan C., et al. An assessment of the utilization of complementary and alternative medication in women with gynecologic or breast malignancies. J Clin Oncol 2004, 22:671-677.
2. Eisenberg D.M., Davis R.B., Ettner S.L., et al. Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. J Am Med Assoc 1998, 280:1569-1575.
3. Kaufman D.W., Kelly J.P., Rosenberg L., Anderson T.E., Mitchell A.A. Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey. J Am Med Assoc 2002, 287:337-344.
4. Yoon S.J., Horne C.H. Herbal products and conventional medicines used by community-residing older women. J Adv Nurs 2001, 33:51-59.
5. Spiegel W., Zidek T., Vutuc C., Maier M., Isak K., Micksche M. Complementary therapies in cancer patients: prevalence and patients motives. Wien Klin Wochenschr 2003, 115:705-709.
6. Harnack L.J., Rydell S.A., Stang J. Prevalence of use of herbal products by adults in the Minneapolis/St Paul, Minn, metropolitan area. Mayo Clin Proc 2001.
7. Von Gruenigen V.E., White L.J., Kirven M.S., et al. A comparison of complementary and alternative medicine use by gynecology and gynecologic oncology patients. Int J Gynecol Cancer 2001, 11:205-209.
8. Naing A., Stephen S.K., Frenkel M., et al. Prevalence of complementary medicine use in a phase 1 clinical trials program: the MD Anderson Cancer Center Experience. Cancer 2011, 117:5142-5150.
9. Levine M.N. Conventional and complementary therapies: a tale of two research standards?. J Clin Oncol 2010, 28:1979-1981.
10. Längler A., Spix C., Edelhäuser F., Kameda G., Kaatsch P., Seifert G. Use of homeopathy in pediatric oncology in Germany. Evid Based Complement Alternat Med 2010, 2011:867151. 10.1155/2011/867151.
11. Rostock M., Naumann J., Guethlin C., Guenther L., Bartsch H.H., Walach H. Classical homeopathy in the treatment of cancer patients - a prospective observational study of two independent cohorts. BMC Cancer 2011, 17(11):19. 10.1186/1471-2407-11-19.
12. Hahnemann C.F.S. Organon der Heilkunst 1989, Haug, Heidelberg. 6th ed.
13. Zandvoort R. The Complete Repertory. Institute for Research in Homeopathic Information and Symptomatology 1994-1996, AJ Leidschendam, The Netherlands.
14. Kent J.T. Lectures on Homeopathic Materia Medica 1905, Boericke and Tafel, Philadelphia, USA.
15. Boericke W. Homeopathic Materia medica with repertory 1980, Homeopathic Book Service, Sittingbourne, Great Britain. 1st ed., 1995.
16. Fayers P., Bottomley A. EORTC Quality of Life Group; Quality of Life Unit: Quality of life research within the EORTC-the EORTC QLQ-C30. European Organisation for Research and Treatment of Cancer. Eur J Cancer 2002, 38(Suppl 4):125-133.
17. Chan AW1, Tetzlaff J.M., Altman D.G., et al. SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med 2013, 158:200-207.
18. Dean M.E., Coulter M.K., Fisher P., et al. Reporting data on homeopathic treatments (RedHot): a supplement to CONSORT. Homeopathy 2007, 96:42-45.
19. Fairclough D.L. Design and analysis of quality of life studies in clinical trials 2002, Chapman & Hall, CRC.
20. Molassiotis A., Fernadez-Ortega P., Pud D., et al. Use of complementary and alternative medicine in cancer patients: a European survey. Ann Oncol 2005, 16:655-663.
21. Wood L., Egger M., Gluud L.L., et al. Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study. Br Med J 2008, 336:601-605.
22. Bonate P.L. Analysis of pretest-posttest designs 2000, Chapman & Hall/CRC, Boca Raton, USA.
23. Odgaard-Jensen J., Vist G.E., Timmer A., et al. Randomisation to protect against selection bias in healthcare trials. Cochrane Database Syst Rev 2011, 4:MR000012.
24. Pildal J., Hrobjartsson A., Jorgensen K.J., et al. Impact of allocation concealment on conclusions drawn from meta-analyses of randomized trials. Int J Epidemiol 2007, 36:847-857.
25. Bill-Axelson A., Holmberg L., Garmo H., et al. Radical prostatectomy or watchful waiting in early prostate cancer. N Engl J Med 2014, 370:932-942.
26. Bottomley A., Tridello G., Coens C., et al. An international phase 3 trial in head and neck cancer: quality of life and symptom results: EORTC 24954 on behalf of the EORTC Head and Neck and the EORTC Radiation Oncology Group. Cancer 2014, 120:390-398.
27. Rey L. Can low-temperature thermoluminescence cast light on the nature of ultra-high dilutions?. Homeopathy 2007, 96:170-174.
28. Pathak S., Multani A.S., Banerji P., Banerji P. Ruta 6 selectively induces cell death in brain cancer cells but proliferation in normal peripheral blood lymphocytes: a novel treatment for human brain cancer. Int J Oncol 2003, 23:975-982.
29. Frenkel M., Mishra B., Yang P., et al. Cytotoxic effects of ultra-diluted remedies on breast cancer cells. Int J Oncol 2010, 36:395-403.
30. Hróbjartsson A., Gøtzsche P.C. Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment. N Engl J Med 2001, 344:1594-1602. [Review].
31. Hróbjartsson A., Gøtzsche P.C. Placebo interventions for all clinical conditions. Cochrane Database Syst Rev 2010, 20(January (1)):CD003974. [Review]. 10.1002/14651858.CD003974.pub3.
32. Münstedt K., Harren H., von Georgi R., Hackethal A. Complementary and alternative medicine: comparison of current knowledge, attitudes and interest among German medical students and doctors. Evid Based Complement Alternat Med 2008, 790951. [Epub 2008 Dec 20].
33. Frenkel M. Homeopathy in cancer care. Altern Ther Health Med 2010, 16:12-16.
34. Montazeri A. Quality of life data as prognostic indicators of survival in cancer patients: an overview of the literature from 1982 to 2008. Health Qual Life Outcomes 2009, 7:102.